Use of MAPK pathway inhibitors for the treatment of Friedreich Ataxia

Use of MAPK pathway inhibitors for the treatment of Friedreich Ataxia . University of Pennsylvania, posted on 05/19/2015

Brief Description: A novel treatment for rare disease Friedreich ataxia using p38 or MK2 kinase inhibitors